Advertisement
Australia markets closed

  • ALL ORDS

    7,999.20
    -83.90 (-1.04%)
     

  • ASX 200

    7,727.60
    -84.20 (-1.08%)
     

  • AUD/USD

    0.6631
    +0.0022 (+0.33%)
     

  • OIL

    77.80
    +0.93 (+1.21%)
     

  • GOLD

    2,335.20
    -2.00 (-0.09%)
     

  • Bitcoin AUD

    104,132.32
    -245.84 (-0.24%)
     

  • CMC Crypto 200

    1,482.04
    +13.93 (+0.95%)
     

  • AUD/EUR

    0.6109
    +0.0005 (+0.08%)
     

  • AUD/NZD

    1.0823
    -0.0005 (-0.04%)
     

  • NZX 50

    11,783.39
    -26.09 (-0.22%)
     

  • NASDAQ

    18,808.35
    +184.96 (+0.99%)
     

  • FTSE

    8,317.59
    -21.64 (-0.26%)
     

  • Dow Jones

    39,069.59
    +4.33 (+0.01%)
     

  • DAX

    18,693.37
    +2.05 (+0.01%)
     

  • Hang Seng

    18,608.94
    -259.77 (-1.38%)
     

  • NIKKEI 225

    38,646.11
    -457.11 (-1.17%)
     

RaySearch and C-RAD sign collaboration agreement

PR Newswire
·2-min read

STOCKHOLM, May 4, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy.

The focus of the collaboration is to investigate how the C-RAD surface scanning technologies can be utilized during treatment planning in RaySearch's treatment planning system RayStation®*. Today, the surfaces from the C-RAD surface guided radiation therapy system, Catalyst+, are used during imaging and treatment. Making the Catalyst+ surfaces available in RayStation has many potential applications. One such application is to extend a cone beam CT image that has a limited field-of-view by using information from the surface scanning. This will lead to more complete representation of the patient's anatomy, which in turn results in a more dependable basis for clinical decisions. As a first outcome of the announced collaboration, the above-described application will be demonstrated at the ongoing trade show ESTRO, with a continuation to explore other applications of the companies' respective products.

Cecilia de Leeuw, CEO and President, C-RAD, says: "We are thrilled about the collaboration with RaySearch, where we will enhance and find new innovative solutions in our common fight against cancer.

Johan Löf, founder and CEO, RaySearch, says: "I look forward to collaborating with C-RAD, which is also located close to us in Sweden. The additional information about the patient's anatomy provided by surface scanning from Catalyst+ has the potential to greatly improve different steps in the radiation therapy treatment planning process in RayStation."

ADVERTISEMENT

CONTACT:

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com

 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/raysearch-and-c-rad-sign-collaboration-agreement,c3973231

The following files are available for download:

https://mb.cision.com/Main/1102/3973231/2778007.pdf

RaySearch Press Release May 4, 2024

https://news.cision.com/raysearch-laboratories/i/press-release-1200x620-c-rad,c3296639

Press-release 1200x620 C RAD

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/raysearch-and-c-rad-sign-collaboration-agreement-302136118.html

SOURCE RaySearch Laboratories